152 related articles for article (PubMed ID: 22528789)
1. Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53.
Yamada S; Kanno H; Kawahara N
J Neurooncol; 2012 Aug; 109(1):7-14. PubMed ID: 22528789
[TBL] [Abstract][Full Text] [Related]
2. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway.
Alonso M; Tamasdan C; Miller DC; Newcomb EW
Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031
[TBL] [Abstract][Full Text] [Related]
3. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
4. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site.
Do TN; Rosal RV; Drew L; Raffo AJ; Michl J; Pincus MR; Friedman FK; Petrylak DP; Cassai N; Szmulewicz J; Sidhu G; Fine RL; Brandt-Rauf PW
Oncogene; 2003 Mar; 22(10):1431-44. PubMed ID: 12629507
[TBL] [Abstract][Full Text] [Related]
5. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.
Senatus PB; Li Y; Mandigo C; Nichols G; Moise G; Mao Y; Brown MD; Anderson RC; Parsa AT; Brandt-Rauf PW; Bruce JN; Fine RL
Mol Cancer Ther; 2006 Jan; 5(1):20-8. PubMed ID: 16432159
[TBL] [Abstract][Full Text] [Related]
6. Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.
Takenobu T; Tomizawa K; Matsushita M; Li ST; Moriwaki A; Lu YF; Matsui H
Mol Cancer Ther; 2002 Oct; 1(12):1043-9. PubMed ID: 12481427
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots.
Skała E; Sitarek P; Toma M; Szemraj J; Radek M; Nieborowska-Skorska M; Skorski T; Wysokińska H; Śliwiński T
J Pharm Pharmacol; 2016 Nov; 68(11):1454-1464. PubMed ID: 27696406
[TBL] [Abstract][Full Text] [Related]
8. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
Daniele S; Barresi E; Zappelli E; Marinelli L; Novellino E; Da Settimo F; Taliani S; Trincavelli ML; Martini C
Oncotarget; 2016 Feb; 7(7):7866-84. PubMed ID: 26761214
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells.
Kim EL; Wüstenberg R; Rübsam A; Schmitz-Salue C; Warnecke G; Bücker EM; Pettkus N; Speidel D; Rohde V; Schulz-Schaeffer W; Deppert W; Giese A
Neuro Oncol; 2010 Apr; 12(4):389-400. PubMed ID: 20308316
[TBL] [Abstract][Full Text] [Related]
10. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
11. A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
Dai F; Chen Y; Song Y; Huang L; Zhai D; Dong Y; Lai L; Zhang T; Li D; Pang X; Liu M; Yi Z
PLoS One; 2012; 7(12):e52162. PubMed ID: 23300602
[TBL] [Abstract][Full Text] [Related]
12. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
13. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.
Koul D; Fu J; Shen R; LaFortune TA; Wang S; Tiao N; Kim YW; Liu JL; Ramnarian D; Yuan Y; Garcia-Echevrria C; Maira SM; Yung WK
Clin Cancer Res; 2012 Jan; 18(1):184-95. PubMed ID: 22065080
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting of wild-type and mutant p53 by small molecule RITA results in the inhibition of N-Myc and key survival oncogenes and kills neuroblastoma cells in vivo and in vitro.
Burmakin M; Shi Y; Hedström E; Kogner P; Selivanova G
Clin Cancer Res; 2013 Sep; 19(18):5092-103. PubMed ID: 23864164
[TBL] [Abstract][Full Text] [Related]
16. The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.
Davitt K; Babcock BD; Fenelus M; Poon CK; Sarkar A; Trivigno V; Zolkind PA; Matthew SM; Grin'kina N; Orynbayeva Z; Shaikh MF; Adler V; Michl J; Sarafraz-Yazdi E; Pincus MR; Bowne WB
Ann Clin Lab Sci; 2014; 44(3):241-8. PubMed ID: 25117093
[TBL] [Abstract][Full Text] [Related]
17. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
[TBL] [Abstract][Full Text] [Related]
18. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
[TBL] [Abstract][Full Text] [Related]
19. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53.
Demma M; Maxwell E; Ramos R; Liang L; Li C; Hesk D; Rossman R; Mallams A; Doll R; Liu M; Seidel-Dugan C; Bishop WR; Dasmahapatra B
J Biol Chem; 2010 Apr; 285(14):10198-212. PubMed ID: 20124408
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
Lou J; Hao Y; Lin K; Lyu Y; Chen M; Wang H; Zou D; Jiang X; Wang R; Jin D; Lam EW; Shao S; Liu Q; Yan J; Wang X; Chen P; Zhang B; Jin B
Mol Cancer; 2020 Sep; 19(1):138. PubMed ID: 32894144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
